Neuroprotection in Stroke w/ Recombinant Fusion Protein
Department of Health and Human Services
Agency Tracking Number:
Solicitation Topic Code:
Small Business Information
ARMAGEN TECHNOLOGIES, INC.
ARMAGEN TECHNOLOGIES, INC., 914 COLORADO BLVD, SANTA MONICA, CA, 90401
Socially and Economically Disadvantaged:
AbstractDESCRIPTION (PROVIDED BY APPLICANT): Stroke is the third leading cause of death and affects nearly 1 million people in the U.S. each year. The cost for rehabilitation of stroke survivors is over $40 billion per year in the U.S. The debilitating effect
* information listed above is at the time of submission.